Quantitative Systematic Strategies LLC Natera, Inc. Transaction History

Quantitative Systematic Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$100.17 - $126.36 $414,403 - $522,751	-4,137 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$86.05 - $119.72 $524,818 - $730,172	-6,099 Reduced 59.58%	4,137 $470,000
Q1 2021 May 06, 2021	SELL	$91.47 - $124.36 $460,734 - $626,401	-5,037 Reduced 32.98%	10,236 $1.04 Million
Q4 2020 Feb 09, 2021	BUY	$66.66 - $111.74 $517,748 - $867,884	7,767 Added 103.48%	15,273 $1.52 Million
Q3 2020 Nov 09, 2020	BUY	$45.89 - $72.67 $344,450 - $545,461	7,506 New	7,506 $542,000

440

117M

254K

263K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.9B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.